Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term continuous ambulatory peritoneal dialysis.

C T Flynn

    Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patient and technique survival for blind and sighted diabetics on continuous ambulatory peritoneal dialysis: a ten-year analysis.

    The International journal of artificial organs·1991
    Same author

    Acute abdominal events and their impact on morbidity and mortality in a CAPD program.

    The International journal of artificial organs·1989
    Same author

    Hemodialysis using a Tenckhoff catheter for venous access and a double pump for blood flow.

    Nephron·1989
    Same author

    Intraperitoneal lithium administration for bipolar affective disorder in a patient on continuous ambulatory peritoneal dialysis.

    The International journal of artificial organs·1987
    Same author

    Renal failure and angiodysplasia of the colon.

    Annals of internal medicine·1985
    Same author

    Membranous glomerulonephropathy (MGN) with pulmonary arterial thrombosis: a case report.

    Iowa medicine : journal of the Iowa Medical Society·1984

    Continuous ambulatory peritoneal dialysis (CAPD) shows varied survival rates among patient groups. Blind diabetics experienced the highest survival and lowest dropout rates on CAPD.

    Area of Science:

    • Nephrology
    • Diabetology
    • Renal Replacement Therapy

    Background:

    • Continuous ambulatory peritoneal dialysis (CAPD) is a key treatment for end-stage renal disease.
    • Diabetic nephropathy is a leading cause of kidney failure, with unique challenges in dialysis patients.
    • Visual impairment in diabetic patients may influence their management and outcomes on dialysis.

    Purpose of the Study:

    • To evaluate the long-term outcomes of continuous ambulatory peritoneal dialysis (CAPD) in a cohort of 65 patients over five years.
    • To compare CAPD survival and dropout rates between non-diabetic, sighted diabetic, and blind diabetic patients.
    • To identify factors influencing treatment success and the need for alternative dialysis modalities.

    Main Methods:

    • Retrospective analysis of 65 patients undergoing CAPD for five years.

    Related Experiment Videos

  • Patient stratification into non-diabetic (33) and diabetic (32) groups.
  • Diabetic subgroup analysis based on visual status (blind vs. sighted).
  • Calculation of cumulative actuarial survival and dropout rates.

    • Main Results:

    • Five-year actuarial survival was highest in blind diabetics, intermediate in non-diabetics, and lowest in sighted diabetics.
    • Blind diabetics exhibited the lowest dropout rates from CAPD.
    • A significant proportion of non-diabetic and sighted diabetic patients required temporary hemodialysis.
    • Temporary hemodialysis facilitated successful return to CAPD for some patients.

    Conclusions:

    • Continuous ambulatory peritoneal dialysis (CAPD) offers a viable long-term treatment option with differential outcomes based on diabetic status and visual impairment.
    • Blind diabetic patients demonstrate superior outcomes and adherence to CAPD compared to sighted diabetics.
    • Careful patient selection and management, including potential use of temporary hemodialysis, are crucial for optimizing CAPD therapy.